Clinical Trial Update: Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effectiveness and safety of frovatriptan for the acute treatment of menstrual migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine

Drugs mentioned

• FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Menstrual Migraine (MM) Headaches | Phase 4 | Status: COMPLETED